{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T19:16:46Z","timestamp":1776280606686,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1124\/jpet.118.249086","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T18:15:12Z","timestamp":1529345712000},"page":"422-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["In Vitro and In Vivo Characterization of Novel Stable Peptidic Ghrelin Analogs: Beneficial Effects in the Settings of Lipopolysaccharide-Induced Anorexia in Mice"],"prefix":"10.1016","volume":"366","author":[{"given":"Martina","family":"Holubov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslava","family":"Blechov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"K\u00e1konov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslav","family":"Kune\u0161","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanka","family":"\u017delezn\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenka","family":"Malet\u00ednsk\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.249086_bib1","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.4155\/fmc.12.76","article-title":"Peptides and peptide conjugates: therapeutics on the upward path","volume":"4","author":"Ahrens","year":"2012","journal-title":"Future Med Chem"},{"key":"10.1124\/jpet.118.249086_bib2","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1042\/BCJ20170032","article-title":"Novel targeted therapies for cancer cachexia","volume":"474","author":"Argil\u00e9s","year":"2017","journal-title":"Biochem J"},{"key":"10.1124\/jpet.118.249086_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mce.2017.02.032","article-title":"IL-1\u03b2 directly suppress ghrelin mRNA expression in ghrelin-producing cells","volume":"447","author":"Bando","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/jpet.118.249086_bib4","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1021\/jm0001727","article-title":"Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a","volume":"43","author":"Bednarek","year":"2000","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.118.249086_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-2094-10-40","article-title":"Ghrelin inhibits LPS-induced release of IL-6 from mouse dopaminergic neurones","volume":"10","author":"Beynon","year":"2013","journal-title":"J Neuroinflammation"},{"key":"10.1124\/jpet.118.249086_bib6","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1152\/ajpregu.00044.2016","article-title":"The ghrelin receptor agonist HM01 mimics the neuronal effects of ghrelin in the arcuate nucleus and attenuates anorexia-cachexia syndrome in tumor-bearing rats","volume":"311","author":"Borner","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.118.249086_bib7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bbi.2012.03.005","article-title":"Lipopolysaccharide inhibits ghrelin-excited neurons of the arcuate nucleus and reduces food intake via central nitric oxide signaling","volume":"26","author":"Borner","year":"2012","journal-title":"Brain Behav Immun"},{"key":"10.1124\/jpet.118.249086_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000108280","article-title":"Regulation of food intake by inflammatory cytokines in the brain","volume":"86","author":"Buchanan","year":"2007","journal-title":"Neuroendocrinology"},{"key":"10.1124\/jpet.118.249086_bib9","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1021\/acs.jmedchem.7b00164","article-title":"Structure-activity study of ghrelin(1-8) resulting in high affinity fluorine-bearing ligands for the ghrelin receptor","volume":"60","author":"Charron","year":"2017","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.118.249086_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jcsm.12023","article-title":"Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved","volume":"6","author":"Chen","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1124\/jpet.118.249086_bib11","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.118.249086_bib12","doi-asserted-by":"crossref","first-page":"8369","DOI":"10.4049\/jimmunol.180.12.8369","article-title":"Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria","volume":"180","author":"Chorny","year":"2008","journal-title":"J Immunol"},{"key":"10.1124\/jpet.118.249086_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040798","article-title":"Therapeutic potential of targeting the ghrelin pathway","volume":"18","author":"Colld\u00e9n","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.118.249086_bib14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jcsm.12185","article-title":"Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia","volume":"8","author":"Conte","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1124\/jpet.118.249086_bib15","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/annonc\/mdx192","article-title":"ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia","volume":"28","author":"Currow","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1124\/jpet.118.249086_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mce.2011.02.012","article-title":"Ghrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?","volume":"340","author":"DeBoer","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/jpet.118.249086_bib17","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1210\/en.2007-0016","article-title":"Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia","volume":"148","author":"DeBoer","year":"2007","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.118.249086_bib18","first-page":"518909","article-title":"Structure and physiological actions of ghrelin","volume":"2013","author":"Delporte","year":"2013","journal-title":"Scientifica (Cairo)"},{"key":"10.1124\/jpet.118.249086_bib19","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1021\/jm070024h","article-title":"Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1","volume":"50","author":"Demange","year":"2007","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.118.249086_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.npep.2014.10.002","article-title":"Endotoxemia-induced muscle wasting is associated with the change of hypothalamic neuropeptides in rats","volume":"48","author":"Duan","year":"2014","journal-title":"Neuropeptides"},{"key":"10.1124\/jpet.118.249086_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/cen.12610","article-title":"Insulin ameliorating endotoxaemia-induced muscle wasting is associated with the alteration of hypothalamic neuropeptides and inflammation in rats","volume":"82","author":"Duan","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1124\/jpet.118.249086_bib22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1124\/jpet.118.249086_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1470-2045(14)71154-4","article-title":"Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials","volume":"16","author":"Garcia","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1124\/jpet.118.249086_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/en.2007-0828","article-title":"Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia","volume":"149","author":"Garcia","year":"2008","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.118.249086_bib25","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1210\/en.2013-1179","article-title":"Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice","volume":"154","author":"Garcia","year":"2013","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.118.249086_bib26","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.neuroscience.2005.03.063","article-title":"Influence of feeding status on neuronal activity in the hypothalamus during lipopolysaccharide-induced anorexia in rats","volume":"134","author":"Gautron","year":"2005","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.118.249086_bib27","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1002\/cncr.27430","article-title":"Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study","volume":"118","author":"Hiura","year":"2012","journal-title":"Cancer"},{"key":"10.1124\/jpet.118.249086_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.mce.2014.06.003","article-title":"Triazole GHS-R1a antagonists JMV4208 and JMV3002 attenuate food intake, body weight, and adipose tissue mass in mice","volume":"393","author":"Holubov\u00e1","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/jpet.118.249086_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-12-381272-8.00008-8","article-title":"Standard sample collections for blood ghrelin measurements","volume":"514","author":"Hosoda","year":"2012","journal-title":"Methods Enzymol"},{"key":"10.1124\/jpet.118.249086_bib30","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1124\/jpet.118.249086_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13539-012-0085-3","article-title":"Effect of ghrelin and its analogues, BIM-28131 and BIM-28125, on the expression of myostatin in a rat heart failure model","volume":"4","author":"Lenk","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1124\/jpet.118.249086_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1620\/tjem.222.7","article-title":"Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats","volume":"222","author":"Li","year":"2010","journal-title":"Tohoku J Exp Med"},{"key":"10.1124\/jpet.118.249086_bib33","doi-asserted-by":"crossref","first-page":"81862","DOI":"10.18632\/oncotarget.13251","article-title":"Growth hormone replacement therapy reduces risk of cancer in adult with growth hormone deficiency: a meta-analysis","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1124\/jpet.118.249086_bib34","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1210\/en.2015-2081","article-title":"Lipopolysacharide rapidly and completely suppresses AgRP neuron-mediated food intake in male mice","volume":"157","author":"Liu","year":"2016","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.118.249086_bib35","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3762\/bjoc.10.118","article-title":"Automated solid-phase peptide synthesis to obtain therapeutic peptides","volume":"10","author":"M\u00e4de","year":"2014","journal-title":"Beilstein J Org Chem"},{"key":"10.1124\/jpet.118.249086_bib36","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1124\/jpet.111.185371","article-title":"Characterization of new stable ghrelin analogs with prolonged orexigenic potency","volume":"340","author":"Malet\u00ednsk\u00e1","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.249086_bib37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/bbrc.2001.5553","article-title":"Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides","volume":"287","author":"Matsumoto","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.118.249086_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2466-13-37","article-title":"Effects of ghrelin treatment on exercise capacity in underweight COPD patients: a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment","volume":"13","author":"Miki","year":"2013","journal-title":"BMC Pulm Med"},{"key":"10.1124\/jpet.118.249086_bib39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MCO.0000000000000075","article-title":"Ghrelin: from discovery to cancer cachexia therapy","volume":"17","author":"Molfino","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1124\/jpet.118.249086_bib40","doi-asserted-by":"crossref","first-page":"e26865","DOI":"10.1371\/journal.pone.0026865","article-title":"Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model","volume":"6","author":"Palus","year":"2011","journal-title":"PLoS One"},{"key":"10.1124\/jpet.118.249086_bib41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.yhbeh.2017.05.018","article-title":"Increase in hypothalamic AMPK phosphorylation induced by prolonged exposure to LPS involves ghrelin and CB1R signaling","volume":"93","author":"Rivas","year":"2017","journal-title":"Horm Behav"},{"key":"10.1124\/jpet.118.249086_bib42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejphar.2017.10.047","article-title":"Z-505 hydrochloride ameliorates chemotherapy-induced anorexia in rodents via activation of the ghrelin receptor, GHSR1a","volume":"818","author":"Shiomi","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.118.249086_bib43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.bjc.6604148","article-title":"Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia\/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study","volume":"98","author":"Strasser","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1124\/jpet.118.249086_bib44","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1124\/jpet.118.249086_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2014.09.025","article-title":"Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice","volume":"743","author":"Tsubouchi","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.118.249086_bib46","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.peptides.2004.03.010","article-title":"Ala-scan of ghrelin (1-14): interaction with the recombinant human ghrelin receptor","volume":"25","author":"Van Craenenbroeck","year":"2004","journal-title":"Peptides"},{"key":"10.1124\/jpet.118.249086_bib47","doi-asserted-by":"crossref","first-page":"F1032","DOI":"10.1152\/ajprenal.00044.2009","article-title":"Ghrelin protects mice against endotoxemia-induced acute kidney injury","volume":"297","author":"Wang","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/jpet.118.249086_bib48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.surg.2007.09.039","article-title":"Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways","volume":"143","author":"Waseem","year":"2008","journal-title":"Surgery"},{"key":"10.1124\/jpet.118.249086_bib49","doi-asserted-by":"crossref","first-page":"H1643","DOI":"10.1152\/ajpheart.01042.2004","article-title":"GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure","volume":"289","author":"Xu","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.118.249086_bib50","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.2174\/092986712799945003","article-title":"Converting peptides into drug leads by lipidation","volume":"19","author":"Zhang","year":"2012","journal-title":"Curr Med Chem"},{"issue":"10 Pt B","key":"10.1124\/jpet.118.249086_bib51","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.bbadis.2017.01.014","article-title":"Therapeutic effect of human ghrelin and growth hormone: attenuation of immunosuppression in septic aged rats","volume":"1863","author":"Zhou","year":"2017","journal-title":"Biochim Biophys Acta"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524262376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524262376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.249086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:00:27Z","timestamp":1739995227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524262376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0022356524262376"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.249086","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vitro and In Vivo Characterization of Novel Stable Peptidic Ghrelin Analogs: Beneficial Effects in the Settings of Lipopolysaccharide-Induced Anorexia in Mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.249086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}